Protein-protein interactions in the allosteric regulation of protein kinases

Current Opinion in Structural Biology

Volumn 16, Issue 6, 2006, Pages 702-709

  Pellicena, Patricia ^a   Kuriyan, John ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM DEPENDENT PROTEIN KINASE 2; CALMODULIN DEPENDENT PROTEIN KINASE II; DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE; RNA DEPENDENT PROTEIN KINASE; SCAFFOLD PROTEIN;

ALLOSTERISM; HUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVIEW; SUPRAMOLECULAR CHEMISTRY;

ALLOSTERIC REGULATION; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DIMERIZATION; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN KINASES; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 33751539464     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sbi.2006.10.007     Document Type: Review

References (72)

1. Pawson T., and Nash P. Assembly of cell regulatory systems through protein interaction domains. Science 300 (2003) 445-452
2. Knighton D.R., Zheng J.H., Ten Eyck L.F., Ashford V.A., Xuong N.H., Taylor S.S., and Sowadski J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253 (1991) 407-414
3. De Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O., and Kim S.H. Crystal structure of cyclin-dependent kinase 2. Nature 363 (1993) 595-602
4. Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J., Massague J., and Pavletich N.P. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376 (1995) 313-320
5. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
6. Schindler T., Sicheri F., Pico A., Gazit A., Levitzki A., and Kuriyan J. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell 3 (1999) 639-648
7. Xu W., Doshi A., Lei M., Eck M.J., and Harrison S.C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3 (1999) 629-638
8. Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B., and Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289 (2000) 1938-1942
9. Nagar B., Hantschel O., Young M.A., Scheffzek K., Veach D., Bornmann W., Clarkson B., Superti-Furga G., and Kuriyan J. Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112 (2003) 859-871
10. Huse M., and Kuriyan J. The conformational plasticity of protein kinases. Cell 109 (2002) 275-282
11. Nolen B., Taylor S., and Ghosh G. Regulation of protein kinases; controlling activity through activation segment conformation. Mol Cell 15 (2004) 661-675
12. Hubbard S.R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16 (1997) 5572-5581
13. Lowe E.D., Noble M.E., Skamnaki V.T., Oikonomakos N.G., Owen D.J., and Johnson L.N. The crystal structure of a phosphorylase kinase peptide substrate complex: kinase substrate recognition. EMBO J 16 (1997) 6646-6658
14. Noble M.E., Endicott J.A., and Johnson L.N. Protein kinase inhibitors: insights into drug design from structure. Science 303 (2004) 1800-1805
15. Knighton D.R., Zheng J.H., Ten Eyck L.F., Xuong N.H., Taylor S.S., and Sowadski J.M. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253 (1991) 414-420
16. Hubbard S.R., Wei L., Ellis L., and Hendrickson W.A. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372 (1994) 746-754
17. Bahler J., and Nurse P. Fission yeast Pom1p kinase activity is cell cycle regulated and essential for cellular symmetry during growth and division. EMBO J 20 (2001) 1064-1073
18. Kentrup H., Becker W., Heukelbach J., Wilmes A., Schurmann A., Huppertz C., Kainulainen H., and Joost H.G. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem 271 (1996) 3488-3495
19. Lee K., Deng X., and Friedman E. Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells. Cancer Res 60 (2000) 3631-3637
20. Lochhead P.A., Sibbet G., Kinstrie R., Cleghon T., Rylatt M., Morrison D.K., and Cleghon V. dDYRK2, a novel dual-specificity tyrosine-phosphorylation-regulated kinase in Drosophila. Biochem J 374 (2003) 381-391
21. Himpel S., Panzer P., Eirmbter K., Czajkowska H., Sayed M., Packman L.C., Blundell T., Kentrup H., Grotzinger J., Joost H.G., et al. Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J 359 (2001) 497-505
22. Lochhead P.A., Sibbet G., Morrice N., and Cleghon V. Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121 (2005) 925-936. The first study to describe in detail the intramolecular autophosphorylation of the activation loop of a protein kinase. The study presents evidence of a translational intermediate with residue and inhibitor specificities that differ from those of the mature kinase.
23. Bhattacharyya R.P., Remenyi A., Good M.C., Bashor C.J., Falick A.M., and Lim W.A. The Ste5 scaffold allosterically modulates signaling output of the yeast mating pathway. Science 311 (2006) 822-826. The allosteric regulation of a kinase by a scaffolding protein is uncovered. Structural and biochemical studies help put forth a model for the mechanism of regulation. Yeast genetics is used to further explore the consequences of the allosteric activation of the kinase. This is the first detailed demonstration that scaffold proteins can play an active role in signaling.
24. Batkin M., Schvartz I., and Shaltiel S. Snapping of the carboxyl terminal tail of the catalytic subunit of PKA onto its core: characterization of the sites by mutagenesis. Biochemistry 39 (2000) 5366-5373
25. Brown K., Vial S.C., Dedi N., Long J.M., Dunster N.J., and Cheetham G.M. Structural basis for the interaction of TAK1 kinase with its activating protein TAB1. J Mol Biol 354 (2005) 1013-1020. The crystal structure of a complex between a kinase domain fused to a segment of a protein known to stimulate autophosphorylation is presented.
26. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 18 (1999) 6112-6120
27. Romano P.R., Garcia-Barrio M.T., Zhang X., Wang Q., Taylor D.R., Zhang F., Herring C., Mathews M.B., Qin J., and Hinnebusch A.G. Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol 18 (1998) 2282-2297
28. Carpick B.W., Graziano V., Schneider D., Maitra R.K., Lee X., and Williams B.R. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J Biol Chem 272 (1997) 9510-9516
29. Cosentino G.P., Venkatesan S., Serluca F.C., Green S.R., Mathews M.B., and Sonenberg N. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc Natl Acad Sci USA 92 (1995) 9445-9449
30. Romano P.R., Green S.R., Barber G.N., Mathews M.B., and Hinnebusch A.G. Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2 alpha kinase DAI in Saccharomyces cerevisiae. Mol Cell Biol 15 (1995) 365-378
31. Zhang F., Romano P.R., Nagamura-Inoue T., Tian B., Dever T.E., Mathews M.B., Ozato K., and Hinnebusch A.G. Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem 276 (2001) 24946-24958
32. ••], are combined to put forth a mechanism for PKR regulation.
33. ••], are used to present a model in which dimerization, activation loop phosphorylation and substrate recognition may function together.
34. Gay L.M., Ng H.L., and Alber T. A conserved dimer and global conformational changes in the structure of apo-PknE Ser/Thr protein kinase from Mycobacterium tuberculosis. J Mol Biol 360 (2006) 409-420. The back-to-back dimer seen in PKR has also been described for PknE and other M. tuberculosis kinases, suggesting there may be a common mechanism for the activation of several protein kinase families.
35. Young T.A., Delagoutte B., Endrizzi J.A., Falick A.M., and Alber T. Structure of Mycobacterium tuberculosis PknB supports a universal activation mechanism for Ser/Thr protein kinases. Nat Struct Biol 10 (2003) 168-174
36. Ortiz-Lombardia M., Pompeo F., Boitel B., and Alzari P.M. Crystal structure of the catalytic domain of the PknB serine/threonine kinase from Mycobacterium tuberculosis. J Biol Chem 278 (2003) 13094-13100
37. Sicheri F., Moarefi I., and Kuriyan J. Crystal structure of the Src family tyrosine kinase Hck. Nature 385 (1997) 602-609
38. Xu W., Harrison S.C., and Eck M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385 (1997) 595-602
39. q forms an effector-like interaction with GRK2.
40. Pirruccello M., Sondermann H., Pelton J.G., Pellicena P., Hoelz A., Chernoff J., Wemmer D.E., and Kuriyan J. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases. J Mol Biol 361 (2006) 312-326. A re-examination of PAK1 crystal structures, combined with NMR and mutational analyses, uncovers an interface that is used as a docking site in the transphosphorylation reaction of PAK2 kinase domains.
41. Lei M., Robinson M.A., and Harrison S.C. The active conformation of the PAK1 kinase domain. Structure 13 (2005) 769-778
42. Pellicena P., and Miller W.T. Coupling kinase activation to substrate recognition in SRC-family tyrosine kinases. Front Biosci 7 (2002) d256-d267
43. Cheng K.Y., Noble M.E., Skamnaki V., Brown N.R., Lowe E.D., Kontogiannis L., Shen K., Cole P.A., Siligardi G., and Johnson L.N. The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition. J Biol Chem 281 (2006) 23167-23179
44. Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 37 suppl 4 (2001) S3-S8
45. Wedegaertner P.B., and Gill G.N. Activation of the purified protein tyrosine kinase domain of the epidermal growth factor receptor. J Biol Chem 264 (1989) 11346-11353
46. Mohammadi M., Honegger A., Sorokin A., Ullrich A., Schlessinger J., and Hurwitz D.R. Aggregation-induced activation of the epidermal growth factor receptor protein tyrosine kinase. Biochemistry 32 (1993) 8742-8748
47. Yarden Y., and Schlessinger J. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26 (1987) 1434-1442
48. Gotoh N., Tojo A., Hino M., Yazaki Y., and Shibuya M. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem Biophys Res Commun 186 (1992) 768-774
49. Burke C.L., and Stern D.F. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface. Mol Cell Biol 18 (1998) 5371-5379
50. Moriki T., Maruyama H., and Maruyama I.N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J Mol Biol 311 (2001) 1011-1026
51. Stamos J., Sliwkowski M.X., and Eigenbrot C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 277 (2002) 46265-46272
52. Wood E.R., Truesdale A.T., McDonald O.B., Yuan D., Hassell A., Dickerson S.H., Ellis B., Pennisi C., Horne E., Lackey K., et al. A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res 64 (2004) 6652-6659
53. Zhang X., Gureasko J., Shen K., Cole P.A., and Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125 (2006) 1137-1149. Crystallographic, biochemical and mutational analyses are combined to demonstrate that the activation of EGF receptor is accomplished by the formation of a catalytic domain asymmetric dimer. The C-lobe of one kinase domain interacts with the N-lobe of the dimer partner in a manner analogous to the activation of Cdk2 by cyclin A. The structure of the kinase C-lobe is, however, distinct from that of the cyclins.
54. Landau M., Fleishman S.J., and Ben-Tal N. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains. Structure 12 (2004) 2265-2275
55. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2 (2001) 127-137
56. Padyana A.K., Qiu H., Roll-Mecak A., Hinnebusch A.G., and Burley S.K. Structural basis for autoinhibition and mutational activation of eukaryotic initiation factor 2alpha protein kinase GCN2. J Biol Chem 280 (2005) 29289-29299
57. Levinson N.M., Kuchment O., Shen K., Young M.A., Koldobskiy M., Karplus M., Cole P.A., and Kuriyan J. A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol 4 (2006) e144
58. Rudolph M.J., Amodeo G.A., Bai Y., and Tong L. Crystal structure of the protein kinase domain of yeast AMP-activated protein kinase Snf1. Biochem Biophys Res Commun 337 (2005) 1224-1228
59. Nayak V., Zhao K., Wyce A., Schwartz M.F., Lo W.S., Berger S.L., and Marmorstein R. Structure and dimerization of the kinase domain from yeast Snf1, a member of the Snf1/AMPK protein family. Structure 14 (2006) 477-485. The crystal structure of Snf1 reveals a kinase dimer with both catalytic domains in an inactive conformation. Dimer formation is also demonstrated in solution. The catalytic domains are found to resemble the inhibited form of Cdk2. The structure of Snf1 is also discussed in [58], but that study concluded that dimer formation in solution was unlikely.
60. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 29 (2004) 18-24
61. 2+/calmodulin-dependent protein kinase II. Biochem J 364 (2002) 593-611
62. 2+ oscillations. Science 279 (1998) 227-230
63. Kolodziej S.J., Hudmon A., Waxham M.N., and Stoops J.K. Three-dimensional reconstructions of calcium/calmodulin-dependent (CaM) kinase IIalpha and truncated CaM kinase IIalpha reveal a unique organization for its structural core and functional domains. J Biol Chem 275 (2000) 14354-14359
64. Morris E.P., and Torok K. Oligomeric structure of alpha-calmodulin-dependent protein kinase II. J Mol Biol 308 (2001) 1-8
65. Woodgett J.R., Davison M.T., and Cohen P. The calmodulin-dependent glycogen synthase kinase from rabbit skeletal muscle. Purification, subunit structure and substrate specificity. Eur J Biochem 136 (1983) 481-487
66. 2+/calmodulin-dependent kinase II. Mol Cell 11 (2003) 1241-1251
67. 2+/CaM kinase II. FEBS J 273 (2006) 682-694
68. Rosenberg O.S., Deindl S., Sung R.J., Nairn A.C., and Kuriyan J. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell 123 (2005) 849-860. The unexpected observation that the basic CaMK-II unit is a catalytic domain dimer in which the regulatory regions of each form a coiled-coil strut is used to explain certain biochemical features of the enzyme. Together with other biophysical studies and small-angle X-ray scattering (SAXS) analysis of the holoenzyme, the dimer seen in the crystal structure is used to present a model for the structure of the holoenzyme.
69. Hu S.H., Parker M.W., Lei J.Y., Wilce M.C., Benian G.M., and Kemp B.E. Insights into autoregulation from the crystal structure of twitchin kinase. Nature 369 (1994) 581-584
70. Goldberg J., Nairn A.C., and Kuriyan J. Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I. Cell 84 (1996) 875-887
71. 2+-calmodulin-dependent protein kinase II. J Biol Chem 279 (2004) 12484-12494
72. Bahadur R.P., Chakrabarti P., Rodier F., and Janin J. A dissection of specific and non-specific protein-protein interfaces. J Mol Biol 336 (2004) 943-955